Orthofix Medical Inc. began in a small farmhouse in Verona Italy in 1980 when orthopedic researcher Giovanni De Bastiani recognized the bone’s natural repair capability, a concept he called “dynamization.” With that in mind, he created the first external fixation device. Today, Orthofix has grown to more than 1,200 employees with locations in the U.S., Italy, Germany, France, the U.K., Brazil, and Australia. Our products help patients in more than 70 countries around the world.
The Company’s mission is to deliver innovative, quality-driven solutions as we partner with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, the company has two strategic business units: Spine and Orthopedics. Orthofix products are widely distributed via the company's sales representatives and distributors. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as MTF Biologics, the Orthopedic Research and Education Foundation, and the Texas Scottish Rite Hospital for Children.
Orthofix makes a difference in the lives of others by providing our surgeon customers with innovative medical devices to meet the needs of their patients. Every day we are optimizing our operations, improving efficiencies, and examining our systems to provide the best support possible to our representatives, surgeons and patients.
The Company’s mission is to deliver innovative, quality-driven solutions as we partner with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, the company has two strategic business units: Spine and Orthopedics. Orthofix products are widely distributed via the company's sales representatives and distributors. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as MTF Biologics, the Orthopedic Research and Education Foundation, and the Texas Scottish Rite Hospital for Children.
Orthofix makes a difference in the lives of others by providing our surgeon customers with innovative medical devices to meet the needs of their patients. Every day we are optimizing our operations, improving efficiencies, and examining our systems to provide the best support possible to our representatives, surgeons and patients.
Location: United States, Texas, Lewisville
Employees: 1001-5000
Founded date: 1980
Investors 2
| Date | Name | Website |
| 10.07.2026 | K2 HealthV... | k2hv.com |
| 10.07.2026 | Novatio Ve... | novatioven... |
Mentions in press and media 22
| Date | Title | Description |
| 12.08.2026 | Notable Systems Receives Investment From XiFin | Notable Systems, a Denver, CO-based developer of agentic AI automation for healthcare revenue cycle operations, received a strategic investment from XiFin, Inc. as part of its Series B financing. The amount of the deal was not disclosed. Th... |
| 25.06.2026 | OssDsign appoints Adam McCollister as new Vice President of Sales | OssDsign appoints Adam McCollister as new Vice President of Sales Thu, Jun 25, 2026 17:30 CET Report this content OssDsign Appoints Adam McCollister as Vice President of Sales to Accelerate U.S. Growth of Catalyst Platform Uppsala, Sweden, ... |
| 07.04.2025 | John Bostjancic_ From Orthofix to Sonendo – A Journey of Financial Leadership and Innovation | Share Share Share Share Email Statistics don’t lie, but they also don’t tell the whole truth. At the back of every financial achievement, there is a decision-maker shaping the future. John Bostjancic is such a decision-maker. His profession... |
| 14.01.2025 | MicroAire appoints Remco Maljers as Head of International Sales | CHARLOTTESVILLE, Va., Jan. 14, 2025 /PRNewswire/ -- MicroAire Surgical Instruments, a Marmon Holdings | Berkshire Hathaway company focused on plastic and upper extremity surgery, is pleased to announce the appointment of Remco Maljers as it... |
| 02.10.2024 | ROTH to Host 3rd Annual Healthcare Opportunities Conference on October 9 in New York City | Conference to Feature Leading Healthcare Companies and Institutional Investors for 1x1/Small Group Meetings and Panels NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to a... |
| 27.08.2024 | Orthofix Medical Inc. Sued for Securities Law Violations - Contact The Rosen Law Firm Before October 21, 2024 to Discuss Your Rights - OFIX | NEW YORK, Aug. 27, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 1... |
| 11.03.2024 | Artificial Disc Replacement (ADR) Market Predicted to Garner $1.3 Bn by 2030 | CAGR of 12.3% | Vantage Market Research | Vantage Market Research Artificial Disc Replacement Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2030 WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- The Global Artifi... |
| 11.03.2024 | Sports Medicine Market to hit USD 13.34 billion by 2030, at a CAGR of 5.1% by Exactitude Consultancy | Sports Medicine The Exactitude Consultancy Sports Medicine Market Report –Size, Share, Trends, And Forecast 2024-2030 Rising global interest in sports, coupled with a surge in minimally invasive solutions, fuels strong demand for sports med... |
| 04.05.2023 | Orthofix STIM onTrack Recognized for Patient Engagement Innovation in 2023 MedTech Breakthrough Awards Program | “This award belongs to our dedicated team of employees who always put the patient first – we are grateful to them, and we are very pleased to accept this award from MedTech Breakthrough.” - Kevin Kenny, President of Orthofix Global Spine LO... |
| 04.08.2022 | CGBio Signing a North America Out-license Contract on "Novosis rhBMP-2," a Bone Substitute with Orthofix, USA | Embarking on a successful journey of exporting its home-grown product technology to North America, the largest market for bone substitutes Enabling fast bone formation by applying bone morphogenetic protein (rhBMP-2) and next-generation syn... |
Show more